Education
About Us
Working with TipRanks
Follow Us
AbbVie (ABBV)
NYSE:ABBV
Total Valuation
AbbVie has a market cap or net worth of $327.65B. The enterprise value is $340.28B.
Market Cap$327.65B
Enterprise Value$340.28B
Share Statistics
AbbVie has 1,766,403,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,766,403,100
Owned by Insiders0.07%
Owned by Institutions14.10%
Financial Efficiency
AbbVie’s return on equity (ROE) is 1.29 and return on invested capital (ROIC) is 18.58%.
Return on Equity (ROE)1.29
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)18.58%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee1.02M
Profits Per Employee77.93K
Employee Count55,000
Asset Turnover0.42
Inventory Turnover4.04
Valuation Ratios
The current PE Ratio of AbbVie is 73.48. AbbVie’s PEG ratio is 9.22.
PE Ratio73.48
PS Ratio0.00
PB Ratio16.59
Price to Fair Value94.54
Price to FCF11.80
Price to Operating Cash Flow11.47
PEG Ratio9.22
Income Statement
In the last 12 months, AbbVie had revenue of 56.33B and earned 4.28B in profits. Earnings per share was 2.40.
Revenue56.33B
Gross Profit39.43B
Operating Income16.63B
Pretax Income3.72B
Net Income4.28B
EBITDA14.91B
Earnings Per Share (EPS)2.40
Cash Flow
In the last 12 months, operating cash flow was 16.40B and capital expenditures -1.02B, giving a free cash flow of 15.38B billion.
Operating Cash Flow16.40B
Free Cash Flow15.38B
Free Cash Flow per Share8.71
Dividends & Yields
AbbVie pays an annual dividend of $1.64, resulting in a dividend yield of 3.54%
Dividend Per Share$1.64
Dividend Yield3.54%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.33
52-Week Price Change11.17%
50-Day Moving Average184.89
200-Day Moving Average186.32
Relative Strength Index (RSI)45.11
Average Volume (3m)5.90M
Important Dates
AbbVie upcoming earnings date is Jul 25, 2025, TBA Not Confirmed.
Last Earnings DateApr 25, 2025
Next Earnings DateJul 25, 2025
Ex-Dividend DateApr 15, 2025
Financial Position
AbbVie as a current ratio of 0.66, with Debt / Equity ratio of 366.70%
Current Ratio0.66
Quick Ratio0.55
Debt to Market Cap0.21
Net Debt to EBITDA4.13
Interest Coverage Ratio5.92
Taxes
In the past 12 months, AbbVie has paid -570.00M in taxes.
Income Tax-570.00M
Effective Tax Rate-0.15
Enterprise Valuation
AbbVie EV to EBITDA ratio is 25.22, with an EV/FCF ratio of 21.08.
EV to Sales6.67
EV to EBITDA25.22
EV to Free Cash Flow21.08
EV to Operating Cash Flow19.99
Balance Sheet
AbbVie has $5.18B in cash and marketable securities with $69.89B in debt, giving a net cash position of $64.71B billion.
Cash & Marketable Securities$5.18B
Total Debt$69.89B
Net Cash$64.71B
Net Cash Per Share$36.64
Tangible Book Value Per Share-$51.81
Margins
Gross margin is 70.00%, with operating margin of 29.51%, and net profit margin of 7.59%.
Gross Margin70.00%
Operating Margin29.51%
Pretax Margin6.60%
Net Profit Margin7.59%
EBITDA Margin26.47%
EBIT Margin11.58%
Analyst Forecast
The average price target for AbbVie is $212.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$212.80
Price Target Upside14.84% Upside
Analyst ConsensusModerate Buy
Analyst Count17
Revenue Growth Forecast5.45%
EPS Growth Forecast-30.21%